Sign inGet started

SUVARI TRICIA BORGA

Insider CIK 1238408 · GBT Chief Legal Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-0626,454— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-0642,400— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-0628,628— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-0615,460— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-0613,814— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-069,060— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-063,125— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-06100,000— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-0640,000— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-0640,000— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-0638,500— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-0638,739— $00SEC↗
GBT Global Blood Therapeutics, D To issuer2022-10-052022-10-0643,077— $00SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2022-09-012022-09-062,763— $013,814SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2022-09-012022-09-062,208— $015,460SEC↗
GBT Global Blood Therapeutics, M Exercise2022-09-012022-09-062,208— $044,958SEC↗
GBT Global Blood Therapeutics, M Exercise2022-09-012022-09-062,763— $042,750SEC↗
GBT Global Blood Therapeutics, F Tax w/h2022-09-012022-09-061,881$68.15 $128.2K43,077SEC↗
GBT Global Blood Therapeutics, A Award2022-08-312022-09-06385$25.37 $9.8K39,987SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2022-08-012022-08-033,125— $03,125SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2022-08-012022-08-033,020— $09,060SEC↗
GBT Global Blood Therapeutics, F Tax w/h2022-08-012022-08-032,126$32.40 $68.9K39,602SEC↗
GBT Global Blood Therapeutics, M Exercise2022-08-012022-08-036,145— $041,728SEC↗
GBT Global Blood Therapeutics, A Award deriv2022-03-012022-03-0328,628— $028,628SEC↗
GBT Global Blood Therapeutics, A Award deriv2022-03-012022-03-0317,668— $017,668SEC↗
GBT Global Blood Therapeutics, A Award deriv2022-03-012022-03-0317,668— $017,668SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2022-03-012022-03-032,763— $016,577SEC↗
GBT Global Blood Therapeutics, M Exercise2022-03-012022-03-032,763— $036,609SEC↗
GBT Global Blood Therapeutics, F Tax w/h2022-03-012022-03-03956$29.87 $28.6K35,653SEC↗
GBT Global Blood Therapeutics, A Award2022-02-282022-03-03453$25.37 $11.5K33,846SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2022-02-012022-02-033,125— $06,250SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2022-02-012022-02-033,020— $012,080SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2022-02-012022-02-033,250— $00SEC↗
GBT Global Blood Therapeutics, F Tax w/h2022-02-012022-02-033,470$29.33 $101.8K33,393SEC↗
GBT Global Blood Therapeutics, M Exercise2022-02-012022-02-039,395— $036,863SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2021-09-012021-09-032,762— $019,340SEC↗
GBT Global Blood Therapeutics, M Exercise2021-09-012021-09-032,762— $028,515SEC↗
GBT Global Blood Therapeutics, F Tax w/h2021-09-012021-09-031,047$29.85 $31.3K27,468SEC↗
GBT Global Blood Therapeutics, A Award2021-08-312021-09-0343$24.39 $1.0K25,753SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2021-08-012021-08-033,020— $015,100SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2021-08-012021-08-033,125— $09,375SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2021-08-012021-08-033,250— $03,250SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2021-08-012021-09-243,125— $09,375SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2021-08-012021-09-243,020— $015,100SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2021-08-012021-09-243,250— $03,250SEC↗
GBT Global Blood Therapeutics, F Tax w/h2021-08-012021-08-033,250$27.33 $88.8K25,710SEC↗
GBT Global Blood Therapeutics, M Exercise2021-08-012021-08-039,395— $028,960SEC↗
GBT Global Blood Therapeutics, F Tax w/h2021-08-012021-09-243,250$27.33 $88.8K25,710SEC↗
GBT Global Blood Therapeutics, M Exercise2021-08-012021-09-249,395— $028,960SEC↗
GBT Global Blood Therapeutics, A Award deriv2021-03-012021-03-0322,102— $022,102SEC↗
GBT Global Blood Therapeutics, A Award deriv2021-03-012021-03-0338,739— $038,739SEC↗
GBT Global Blood Therapeutics, A Award2021-02-282021-03-03342$36.21 $12.4K19,565SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2021-02-012021-02-033,250— $06,500SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2021-02-012021-02-033,020— $018,120SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2021-02-012021-02-033,125— $012,500SEC↗
GBT Global Blood Therapeutics, M Exercise2021-02-012021-02-039,395— $022,622SEC↗
GBT Global Blood Therapeutics, F Tax w/h2021-02-012021-02-033,399$49.49 $168.2K19,223SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2020-08-012020-08-043,125— $015,625SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2020-08-012020-08-043,020— $021,140SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2020-08-012020-08-043,250— $09,750SEC↗
GBT Global Blood Therapeutics, M Exercise2020-08-012020-08-049,395— $017,084SEC↗
GBT Global Blood Therapeutics, F Tax w/h2020-08-012020-08-043,857$67.48 $260.3K13,227SEC↗
GBT Global Blood Therapeutics, A Award2020-07-312020-08-04248$36.68 $9.1K7,689SEC↗
GBT Global Blood Therapeutics, A Award deriv2020-06-012020-06-0342,400— $042,400SEC↗
GBT Global Blood Therapeutics, S Sale2020-04-202020-04-224,080$75.00 $306.0K7,441SEC↗
GBT Global Blood Therapeutics, A Award deriv2020-02-032020-02-0438,500— $038,500SEC↗
GBT Global Blood Therapeutics, A Award deriv2020-02-032020-02-0424,160— $024,160SEC↗
GBT Global Blood Therapeutics, S Sale2020-02-032020-02-041,308$62.81 $82.2K11,521SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2020-02-012020-02-043,250— $013,000SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2020-02-012020-02-043,125— $018,750SEC↗
GBT Global Blood Therapeutics, F Tax w/h2020-02-012020-02-042,295$65.26 $149.8K12,829SEC↗
GBT Global Blood Therapeutics, M Exercise2020-02-012020-02-046,375— $015,124SEC↗
GBT Global Blood Therapeutics, A Award2020-01-312020-02-04401$36.68 $14.7K8,749SEC↗
GBT Global Blood Therapeutics, S Sale2020-01-022020-01-031,308$79.78 $104.4K8,348SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-12-132019-12-175,000— $00SEC↗
GBT Global Blood Therapeutics, M Exercise2019-12-132019-12-175,000— $011,752SEC↗
GBT Global Blood Therapeutics, F Tax w/h2019-12-132019-12-172,096$76.88 $161.1K9,656SEC↗
GBT Global Blood Therapeutics, S Sale2019-12-022019-12-033,434$66.74 $229.2K6,752SEC↗
GBT Global Blood Therapeutics, S Sale2019-11-012019-11-052,200$48.33 $106.3K10,186SEC↗
GBT Global Blood Therapeutics, S Sale2019-11-012019-11-051,127$48.68 $54.9K12,386SEC↗
GBT Global Blood Therapeutics, S Sale2019-10-012019-10-023,249$48.70 $158.2K13,513SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-08-012019-08-053,250— $016,250SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-08-012019-08-053,125— $021,875SEC↗
GBT Global Blood Therapeutics, M Exercise2019-08-012019-08-056,375— $018,967SEC↗
GBT Global Blood Therapeutics, F Tax w/h2019-08-012019-08-052,205$54.25 $119.6K16,762SEC↗
GBT Global Blood Therapeutics, A Award2019-07-312019-08-05262$36.68 $9.6K12,592SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-04-082019-04-102,000— $05,000SEC↗
GBT Global Blood Therapeutics, M Exercise2019-04-082019-04-102,000— $013,022SEC↗
GBT Global Blood Therapeutics, F Tax w/h2019-04-082019-04-10692$58.51 $40.5K12,330SEC↗
GBT Global Blood Therapeutics, A Award deriv2019-02-012019-02-0540,000— $040,000SEC↗
GBT Global Blood Therapeutics, A Award deriv2019-02-012019-02-0525,000— $025,000SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2019-02-012019-02-053,250— $019,500SEC↗
GBT Global Blood Therapeutics, F Tax w/h2019-02-012019-02-051,241$48.44 $60.1K10,285SEC↗
GBT Global Blood Therapeutics, M Exercise2019-02-012019-02-053,250— $011,526SEC↗
GBT Global Blood Therapeutics, A Award2019-01-312019-04-10318$36.68 $11.7K11,022SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2018-08-012018-08-033,250— $022,750SEC↗
GBT Global Blood Therapeutics, M Exercise2018-08-012018-08-033,250— $09,400SEC↗
GBT Global Blood Therapeutics, F Tax w/h2018-08-012018-08-031,124$43.15 $48.5K8,276SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2018-02-142018-02-162,000— $07,000SEC↗
GBT Global Blood Therapeutics, F Tax w/h2018-02-142018-02-16692$62.30 $43.1K6,150SEC↗
GBT Global Blood Therapeutics, M Exercise2018-02-142018-02-162,000— $06,842SEC↗
GBT Global Blood Therapeutics, A Award deriv2018-02-012018-02-0226,000— $026,000SEC↗
GBT Global Blood Therapeutics, A Award deriv2018-02-012018-02-0240,000— $040,000SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2018-01-312018-02-022,000— $09,000SEC↗
GBT Global Blood Therapeutics, F Tax w/h2018-01-312018-02-02692$57.90 $40.1K3,749SEC↗
GBT Global Blood Therapeutics, M Exercise2018-01-312018-02-022,000— $04,441SEC↗
GBT Global Blood Therapeutics, F Tax w/h2018-01-242018-01-26682$58.15 $39.7K2,441SEC↗
GBT Global Blood Therapeutics, M Exercise2018-01-242018-01-262,000— $03,123SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2018-01-162018-01-182,000— $013,000SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2018-01-162018-01-262,000— $011,000SEC↗
GBT Global Blood Therapeutics, M Exercise2018-01-162018-01-182,000— $02,000SEC↗
GBT Global Blood Therapeutics, F Tax w/h2018-01-162018-01-18877$52.10 $45.7K1,123SEC↗
GBT Global Blood Therapeutics, A Award deriv2017-08-112017-08-1415,000— $015,000SEC↗
GBT Global Blood Therapeutics, A Award deriv2016-10-112016-10-12100,000— $0100,000SEC↗